CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 86 filers reported holding CRINETICS PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $5,554,000 | +33.4% | 294,620 | +8.2% | 5.57% | +65.1% |
| Q1 2021 | $4,162,000 | +31.6% | 272,393 | +21.5% | 3.37% | +40.0% |
| Q4 2020 | $3,162,000 | -16.4% | 224,129 | -7.1% | 2.41% | -19.3% |
| Q3 2020 | $3,781,000 | -8.7% | 241,278 | +2.1% | 2.98% | +3.0% |
| Q2 2020 | $4,142,000 | +3.0% | 236,394 | -16.3% | 2.90% | -26.8% |
| Q1 2020 | $4,022,000 | -22.1% | 282,272 | +37.2% | 3.96% | +14.4% |
| Q4 2019 | $5,162,000 | – | 205,726 | – | 3.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,030,616 | $31,028,000 | 6.04% |
| 5AM Venture Management, LLC | 1,362,286 | $20,816,000 | 3.75% |
| Burrage Capital Management LLC | 272,393 | $4,162,000 | 3.37% |
| Altium Capital Management LP | 361,930 | $5,530,000 | 1.54% |
| Vivo Capital, LLC | 2,214,138 | $33,832,000 | 1.19% |
| Bain Capital Life Sciences Investors, LLC | 1,071,428 | $16,371,000 | 0.93% |
| Perceptive Advisors | 3,659,381 | $51,606,000 | 0.65% |
| New Leaf Venture Partners, L.L.C. | 141,000 | $2,154,000 | 0.50% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,003,688 | $30,616,000 | 0.45% |
| Opaleye Management Inc. | 188,000 | $2,873,000 | 0.42% |